Table 1. Tumor cell line characteristics.
CDH1 status, cell line | CDH1 status, | ||||||
cell line | origin | established | nucleotide | meth. | protein | primary | ref. |
IPH-926 | ILBC1 | 2006 | 241ins4 (homo) | neg | neg | 241ins4 (homo) | [20]–[22] |
MDA-MB-134 | ILBC2 | 1973 | 688del145 (homo) | neg | neg | na | [23]–[25] |
SUM-44-PE | ILBC2 | 1993 | 1269delT (homo) | neg | neg | na | [5]; [26] |
MDA-MB-435/M14 | melanoma | 1976 | wt | pos | neg | na | [37]–[39] |
BT-549 | PABC | 1978 | wt | pos | neg | na | [36]; [37] |
origin from ILBC proven by genetic comparison with the corresponding primary ILBC.
origin from ILBC proposed ex post based on molecular features, corresponding primary tumor remained uncharacterized ILBC; infiltrating lobular breast cancer, PABC; papillary breast cancer, homo; homozygous, meth.; aberrant methylation of the CDH1 promoter, neg; negative, pos; positive, na; not assessed.